Funding Roundup – VatorNews

Funding Roundup
VatorNews
Healthcare information technology company Predilytics raised $10 million in additional funding in a round led by Qualcomm Ventures. Flybridge Capital Partners, Foundation Medical, and Highland Capital also (Read more...)
Posted in Uncategorized

Another Alzheimer’s Antibody Goes Down

The clinical failure rate for disease-modifying Alzheimer's therapies remains perfect, unfortunately: a flat 100%. The latest news is from Roche. Their in-licensed amyloid-targeting antibody (gantenerumab, from MorphoSys) came up empty (Read more...)

Posted in Uncategorized